Article

Glaukos selected as top tech startup

Glaukos Corp. has been selected as a Red Herring Top 100 North America Tech Startup, an award honoring the year’s most promising private technology ventures. Glaukos is the only medical device company in North America to be selected for this honor.

Laguna Hills, CA-Glaukos Corp. has been selected as a Red Herring Top 100 North America Tech Startup, an award honoring the year’s most promising private technology ventures. Glaukos is the only medical device company in North America to be selected for this honor.

Red Herring editorial team members selected the most innovative companies from a pool of hundreds from across North America. They evaluated nominees on both quantitative and qualitative criteria, such as financial performance, technology innovation, quality of management, execution of strategy, market penetration, and integration into their respective industries. They also reviewed the track record and standing of startups relative to their sector peers.

“We believe Glaukos Corp. embodies the vision, drive, and innovation that define a successful entrepreneurial venture,” said Alex Vieux, publisher and chief executive officer of Red Herring.

Thomas Burns, Glaukos president and chief executive officer, said, “Glaukos is honored to be selected for this prestigious award. Through our foundational leadership in the emerging minimally invasive glaucoma surgery market class, we are striving to deliver meaningful advances in glaucoma surgery and patient care.”

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.